UP

FDA: Pfizer vaccine 90.7% effective in kids aged 5-11

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

The United States Food and Drug Administration (FDA) revealed on Friday its latest study found Pfizer Inc. and BioNTech SE's vaccine against COVID-19 is 90.7% effective against the disease in children aged between five and 11.

Axar.az reports that the trials were conducted in 2,268 individuals divided into two groups. Those that received both doses of the jab developed an immunity of 90.7% in comparison to those that got a placebo.

Pfizer asked for the FDA's approval for the use of its treatment in kids earlier this month.

Date
2021.10.22 / 20:31
Author
Axar.az
See also

Scientists discover new coronavirus

Azerbaijan performs first deceased donor organ transplants

Fifty countries affected by USAID freeze - WHO

Monkeypox case confirmed in Azerbaijan

WHO calls for international support to fund aid in Gaza

30 metapneumovirus cases reported in Kazakhstan

Human metapneumovirus epidemic reported in China

WHO marks 5 years of COVID-19 and ongoing efforts

Expert warns of public health emergency in Delhi

Gaza polio vaccinations resume after clinic strike

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla